Collagen Solutions is one of many stocks the market is bullish on. Its expected double-digit top-line and bottom-line growth exceeds its peers, and its financially stable position lessens the chances of risk. If a buoyant growth prospect is what you’re after in your next investment, I’ve put together a list of high-growth stocks you may be interested in, based on the latest financial data from each company.
Collagen Solutions plc (AIM:COS)
Collagen Solutions plc develops, manufactures, and supplies medical grade collagen components and biomaterials for use in regenerative medicines, medical devices, and in-vitro diagnostics in Europe, the Middle East, Africa, North America, and Asia. Established in 2013, and currently run by Jamal Rushdy, the company size now stands at 41 people and has a market cap of GBP £8.92M, putting it in the small-cap stocks category.
Driven by the exceptional 94.94% sales growth over the next few years, COS is expected to deliver an excellent earnings growth of 83.84%. Profit growth, coupled with top-line expansion, is a positive indication. This is because net income isn’t artificially inflated by unsustainable activities such as one-off cost-reductions expected in the future. Furthermore, the 96.82% growth in operating cash flows indicates that a large portion of this earnings increase is high-quality, day-to-day cash generated by the business, rather than one-offs. COS ticks the boxes for high-growth generation on all levels of line items, which makes it an appealing stock to dig into deeper. Should you add COS to your portfolio? Take a look at its other fundamentals here.
Arbuthnot Banking Group PLC (AIM:ARBB)
Arbuthnot Banking Group PLC, together with its subsidiaries, provides private and commercial banking products and services in the United Kingdom. Started in 1833, and now run by Henry Angest, the company size now stands at 287 people and with the company’s market cap sitting at GBP £206.06M, it falls under the small-cap category.
ARBB’s forecasted bottom line growth is an exceptional triple-digit, driven by the underlying 70.59% sales growth over the next few years. It appears that ARBB’s profitability may be sustainable as the fundamental push is top-line expansion rather than unmaintainable cost-cutting activities. We see this bottom-line expansion directly benefiting shareholders, with expected positive return on equity of 7.03%. ARBB’s impressive outlook on all aspects makes it a worthy company to spend more time to understand. Thinking of investing in ARBB? Have a browse through its key fundamentals here.